Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DocMorris AGXSWX:DOCM +1.37%65 3-Year FCF Growth Rate is 38.50% as of Jun. 2025. GuruFocus rates XSWX:DOCM with a GF Score™ of 65/100 and a GF Value™ of CHF10.69 (Fairly Valued). The stock has 8 warning signs investors should review. Among 466 Healthcare Providers & Services companies, DocMorris AG ranks better than 76.82% on this metric.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was 38.50% per year.
During the past 5 years, the average Free Cash Flow per Share Growth Rate was 18.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.
During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of DocMorris AG was 38.50% per year. The lowest was -208.40% per year. And the median was -24.90% per year.
DocMorris AG (XSWX:DOCM) 3-Year FCF Growth Rate Explanation
Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.
DocMorris AG 3-Year FCF Growth Rate Related Terms
DocMorris AG 3-Year FCF Growth Rate Competitor Comparison
For the Pharmaceutical Retailers subindustry, DocMorris AG's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DocMorris AG 3-Year FCF Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DocMorris AG's 3-Year FCF Growth Rate distribution charts can be found below:
* The bar in red indicates where DocMorris AG's 3-Year FCF Growth Rate falls into.
This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.
What does a 3-Year FCF Growth Rate of 38.50% mean?
DocMorris AG (XSWX:DOCM) has a 3-Year FCF Growth Rate of 38.50% as of Jun. 2025. 3-Year FCF Growth Rate is the 3-year average growth rate of Free Cash Flow per Share. View historical data for DocMorris AG and its competitors. According to the industry distribution chart, DocMorris AG ranks #108 out of 466 companies in the Healthcare Providers & Services industry, placing it in the top 23.2%.
Is DocMorris AG's 3-Year FCF Growth Rate too high?
DocMorris AG's current 3-Year FCF Growth Rate is 38.50%. The Healthcare Providers & Services industry median 3-Year FCF Growth Rate is 13.35. DocMorris AG's value of 38.50% is 188.4% above this industry median. Based on the distribution chart, DocMorris AG ranks #108 out of 466 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, DocMorris AG has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does DocMorris AG's 3-Year FCF Growth Rate compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, DocMorris AG ranks #108 out of 466 companies for 3-Year FCF Growth Rate. This places DocMorris AG in the top 23% of its industry — outperforming the majority of peers. The industry median 3-Year FCF Growth Rate is 13.35. DocMorris AG's value of 38.50% is 188.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year FCF Growth Rate for a Healthcare Providers & Services company?
The median 3-Year FCF Growth Rate among Healthcare Providers & Services companies is 13.35, based on 466 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year FCF Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year FCF Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DocMorris AG's current 3-Year FCF Growth Rate of 38.50% is 188.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year FCF Growth Rate mean?
A high 3-Year FCF Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year FCF Growth Rate is the 3-year average growth rate of Free Cash Flow per Share. View historical data for DocMorris AG and its competitors. For the Healthcare Providers & Services industry, the median 3-Year FCF Growth Rate is 13.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DocMorris AG's current 3-Year FCF Growth Rate is 38.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DocMorris AG stock overvalued right now?
Based on GuruFocus' analysis, DocMorris AG (XSWX:DOCM) is currently considered Fairly Valued. The stock's GF Value™ is CHF10.69, compared to a current price of CHF10.36 — trading 3.1% below its estimated fair value. The current 3-Year FCF Growth Rate is 38.50% and 188.4% above the Healthcare Providers & Services industry median of 13.35. DocMorris AG's overall GF Score™ is 65/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year FCF Growth Rate calculated?
3-Year FCF Growth Rate is calculated from a company's financial statements. For DocMorris AG (XSWX:DOCM), the current 3-Year FCF Growth Rate is 38.50% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DocMorris AG (XSWX:DOCM) Overvalued in 2026?
Based on GuruFocus' analysis, DocMorris AG stock appears to be undervalued.
The current stock price of CHF10.36 is trading 3.1% below its estimated GF Value™ of CHF10.69.
GuruFocus considers DocMorris AG to be Fairly Valued.
Key valuation signals for XSWX:DOCM:
3-Year FCF Growth Rate: 38.50%
GF Value™: CHF10.69 vs. price of CHF10.36 (3.1% below fair value)
Industry Position: 188.4% above the Healthcare Providers & Services median (#108 of 466)
No single metric tells the full story. See the XSWX:DOCM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DocMorris AG is engaged in the fields of online pharmacy, marketplace, and professional healthcare with brands in Germany and other European countries. Its brands are DocMorris, PromoFarma by DocMorris, and TeleClinic. The Group's reportable segments are Germany and Europe. The Germany segment comprises the mail-order business in drugs and health products, as well as services for mail-order pharmacies. The Europe segment comprises the marketplace business of PromoFarma and Doctipharma. The majority of revenue is generated from Germany segment.
65GF Score
Get the complete analysis for XSWX:DOCM
3-Year FCF Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:DOCM has been successfully added to your 
